Abiopharma

News list

📋 David Kirn (Officer) plans to sell 69K shares of 4D Molecular Therapeutics, Inc. (at $16.76 each, total $1.2M) Filed: Aug 19, 2026 | ID: 000539

Full text

News bot Aug. 19, 2026, 10:29 p.m.
📋 Form 144 Filing: David Kirn

Company: 4D Molecular Therapeutics, Inc.

Filing Date: 2026-08-19

Relationship: Officer
Planned Sale Details:
- Security: Class A Common
- Shares to be Sold: 69,076
- Price per Share: $16.76
- Total Value: $1,157,713.76
- Planned Sale Date: 2026-08-19
- Broker: Goldman Sachs & Co. LLC
- Exchange: NASD
Additional Information:
- SEC File Number: 001-39782
- Issuer Contact Phone: 1-510-505-2680
- Issuer Address: 5858 Horton Street, Suite 455, Emeryville, CA, 94608
- Broker Address: 200 West Street, New York, NY, 10282
- Shares Outstanding: 55244211.0
- Number of Securities to be Sold: 2
- Number of Past Sales: 6
- Remarks: The sales of shares set forth herein are made in connection with a selling plan dated 01/09/2026 that is intended to comply with Rule 10b5-1(c).